Bone Biologics (BBLG) Free Cash Flow (2016 - 2017)
Historic Free Cash Flow for Bone Biologics (BBLG) over the last 2 years, with Q4 2017 value amounting to -$931700.0.
- Bone Biologics' Free Cash Flow rose 2651.39% to -$931700.0 in Q4 2017 from the same period last year, while for Dec 2017 it was -$3.3 million, marking a year-over-year increase of 5455.56%. This contributed to the annual value of -$1.2 million for FY2021, which is 18777.02% down from last year.
- Bone Biologics' Free Cash Flow amounted to -$931700.0 in Q4 2017, which was up 2651.39% from -$561035.0 recorded in Q3 2017.
- Over the past 5 years, Bone Biologics' Free Cash Flow peaked at -$561035.0 during Q3 2017, and registered a low of -$2.5 million during Q1 2016.